NEW YORK, Oct. 24, 2016 /PRNewswire/ --
Report Details
The In Vitro Diagnostics World Market 2016-2026: Clinical
Chemistry, Immunochemistry, Haematology, Microbiology, Genetic
Testing, Point of Care Diagnostics, Blood Glucose Testing,
Infectious Diseases Testing, Rapid Cardiac Market Testing,
Cholesterol Testing, Pregnancy Testing report assesses the global
market for IVDs. The market is first split and forecasted by
submarket.
Six main submarkets are covered, these are the:
- Point-of-care diagnostics (PoC)
- Clinical chemistry
- Immunochemistry
- Haematology
- Microbiology
- Genetic testing
The leading submarket in the IVD industry at present and throughout
the next decade will be point-of-care diagnostics. This submarket
is further subdivided into more specific tests. Blood glucose
testing accounted for over half of the revenue PoC testing made in
2015 due to the rise in prevalence of diabetes.
What are the prospects in the leading regions and
countries?
In our study you will find individual revenue forecasts to 2026 for
the leading regional and national markets:
- US
- Japan
- Germany
- France
- UK
- Spain
- Italy
- China
- India
- Brazil
- Russia
- Rest of the World
The US, Japan and China were the 1st 2nd and 3rd leading
national markets in 2015 and each will retain its place over the
next 10 years. India will be the
fastest growing national market from 2015-2026 with China close behind.
Our new report discusses issues and events affecting the IVD
market. You will find discussions, including qualitative analyses
on:
- The global IVD market
- The IVD market divided by submarket including; point-of-care,
clinical chemistry, haematology, immunochemistry, microbiology and
genetic testing
- The challenges facing the market, such as the US excise tax on
medical devices
- The latest merger & acquisition activity amongst industry
leaders
- 11 different national markets including the 'EU5' and 'BRIC'
nations
Visiongain predicts that the demand for IVDs will increase in line
with the rise in both incidence and prevalence of chronic and
infectious diseases. Health professionals will recognise that if
these diseases can be diagnosed at the earliest stage possible,
then damage to the individual can be minimised in addition to a
reduction of later costs to healthcare systems. IVDs will be able
to stem the economic and clinical costs of chronic and infectious
disease.
The drive to provide patients with diagnostic testing options that
are more accurate, easy-to-use and convenient will sustain growth
in the IVD market during the forecast period of this report.
Our 166 page report provides 38 tables and 72 figures covering 6
different IVD submarkets. 11 individual national markets are
covered in addition to coverage of the leading companies in the
industry. Discover the most lucrative areas in the industry and the
future market prospects. You will see financial results, a primary
interview, industry trends, opportunities, and revenue predictions.
The increasing prevalence of both chronic and infectious diseases
will ensure that there is a great demand for use and innovation of
IVDs over the next decade and beyond.
Read the full report:
http://www.reportlinker.com/p04243658-summary/view-report.html
About Reportlinker
ReportLinker is an award-winning market research solution.
Reportlinker finds and organizes the latest industry data so you
get all the market research you need - instantly, in one place.
http://www.reportlinker.com
__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/in-vitro-diagnostics-world-market-2016-2026-300350114.html
SOURCE Reportlinker